Carelabmed Laboratory'S And Medical Supplies Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 20-12-2024
- Paid Up Capital ₹ 0.10 M
as on 20-12-2024
- Company Age 6 Year, 24 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 881.62%
(FY 2020)
- Profit 534.57%
(FY 2020)
- Ebitda 1114.43%
(FY 2020)
- Net Worth 130.89%
(FY 2020)
- Total Assets 65.33%
(FY 2020)
About Carelabmed Laboratory'S And Medical Supplies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rohan Sabharwal and Sandhya Sabharwal serve as directors at the Company.
- CIN/LLPIN
U74999DL2018PTC343206
- Company No.
343206
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Dec 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Carelabmed Laboratory's And Medical Supplies Private Limited offer?
Carelabmed Laboratory'S And Medical Supplies Private Limited offers a wide range of products and services, including Clinical Thermometer, Clinical Digital Thermometer, Weighing Scales & Measuring Tapes, Personal Weighing Scale, Surgical & ICU Equipments, Oxygen Flow Meter, Hospital Bed and Mattress, ICU Beds, Wheelchairs, Folding Wheelchair.
Who are the key members and board of directors at Carelabmed Laboratory'S And Medical Supplies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohan Sabharwal  | Director | 18-Dec-2018 | Current |
| Sandhya Sabharwal | Director | 18-Dec-2018 | Current |
Financial Performance of Carelabmed Laboratory'S And Medical Supplies.
Carelabmed Laboratory'S And Medical Supplies Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 881.62% increase. The company also saw a substantial improvement in profitability, with a 534.57% increase in profit. The company's net worth Soared by an impressive increase of 130.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Carelabmed Laboratory'S And Medical Supplies?
In 2019, Carelabmed Laboratory'S And Medical Supplies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Carelabmed Laboratory'S And Medical Supplies?
Unlock and access historical data on people associated with Carelabmed Laboratory'S And Medical Supplies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Carelabmed Laboratory'S And Medical Supplies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Carelabmed Laboratory'S And Medical Supplies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
